Dr Marco Gerlinger's Translational Oncogenomics Team are keen to develop new partnerships to continue their work, and to access drugs that could reverse the resistance mechanisms that the team has identified so far.
Professor Uwe Oelfke, Deputy Head of the Division of Radiotherapy and Imaging, is keen to explore new opportunities for collaborative working with industry.
Our Molecular Addictions team, led by Dr Igor Vivanco, is working on a variety of projects that could be developed in collaboration with commercial partners.
In 2018, Professor Emma Hall will be seeking a PhD student to work in her team in the Division of Clinical Studies at the ICR.
Our scientists are pioneering research using high-tech equipment that could help solve the challenge of drug resistance.
Our Epigenetics and Genome Stability team, led by Professor Jessica Downs, is working on a variety of research programmes that could be developed in collaboration with commercial partners.
We’re searching for the brightest minds in cancer research…apply for a #PhD at the ICR, a member institution of University of London.
Chromatography machines enable our structural biology researchers to discover some of life's most fundamental processes and help the ICR develop new treatments to defeat cancer.
Our chromatography machines, used by our structural biology researchers, have been used day in and day out for over ten years. They need replacing so that we can stay at the forefront of research in this field.